bioactive
-
Biologics
Acuitive Technologies Receives FDA 510(k) Clearance for CITREPORE™, A New Synthetic Bioactive Bone Void Filler for Orthopedic Procedures
ALLENDALE, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) — Acuitive Technologies, Inc. today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market CITREPORE, a…
Read More » -
Top Stories
Xenco Medical Unveils the TrabeculeX Continuum, a Breakthrough Convergence of Digital Health and Biomaterials
January 16, 2024 – OrthoSpineNews –Trailblazing medical technology company Xenco Medical has unveiled TrabeculeX Continuum, a novel convergent technology bridging…
Read More » -
Spine
Orthofix Announces 510k Clearance and Full Commercial Launch of OsteoCove, an Advanced Bioactive Synthetic Graft for use in Spine and Orthopedic Procedures
LEWISVILLE, TX, October 12, 2023 /OrthoSpineNews/ Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the 510k…
Read More » -
Biologics
PUR Biologics Announces Launch of PURcore™, a bioActive Moldable Synthetic for Spine Surgery
IRVINE, CA., April 6, 2023 /OrthoSpineNews/ – PUR Biologics, a subsidiary of HippoFi, Inc. (OTC Pink: ORHB), is proud to…
Read More » -
Regulatory
OC Spine a division of OC Medical Devices receives approval for Focus Ti family of TLIF interbody devices featuring xCELLerate bioactive surface technology
Savannah GA, October 18, 2022 /OrthoSpineNews/ – OC Spine a division of OC Medical Devices a privately held medical device…
Read More » -
Biologics
Orthofix Expands Synthetic Bone Growth Offerings with Full Market Launch of Opus BA – a Bioactive Solution for Spine Procedures
February 22, 2022 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus,…
Read More » -
Biologics
Spine Wave Announces the Commercial Launch of Tornado® Bioactive Bone Graft Matrix
SHELTON, Conn., Sept. 24, 2020 (GLOBE NEWSWIRE) — Spine Wave is pleased to announce the commercial launch of Tornado® Bioactive Bone…
Read More » -
Biologics
Bioventus Reports First Use of its SIGNAFUSE® Bioactive Bone Graft in Strip Format
September 2, 2020 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus is sharing results of its first in-patient use of the new SIGNAFUSE Bioactive Bone Graft strips. Rick…
Read More » -
Biologics
Baxter Announces U.S. FDA Clearance of Altapore Shape Bioactive Bone Graft for Use in Surgery
July 9, 2020 DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced U.S. Food…
Read More » -
Regulatory
HAPPE Spine™ Announces Additional Technology Patent For Porous And Bioactive PEEK
HOLLAND, Mich., July 8, 2020 /PRNewswire/ — HAPPE Spine announces that it has received notice of allowance from the U.S. Patent and Trademark Office…
Read More » -
Biologics
On the Road to Taking Bioprinting to Preclinical and Clinical Applications
by Elizabeth Hofheinz, M.P.H., M.Ed. Engineering researchers from Texas A&M University are furthering the move toward patient-specific 3D constructs. Their…
Read More » -
Biologics
BBS-Bioactive Bone Substitutes Plc: We are pleased to announce that the clinical result of ARTEBONE® is positive yielding an outcome similar to patient’s own bone graft
19.2.2020 The clinical investigation run by BBS-Bioactive Bone Substitutes Oyj in clinical centers in Finland and Poland has been finalized…
Read More » -
Hospitals
RTI Surgical® Receives Regulatory Clearances, Expands Distribution of nanOss® Bioactive in Australia, Europe
September 19, 2016 ALACHUA, Fla. (DATE) – RTI Surgical (RTI) (Nasdaq: RTIX), a global surgical implant company, announced it has…
Read More » -
Biologics
Global Bioactive Wound Care Market to Post a CAGR of Close to 14% from 2016-2020, Predicts Technavio
June 13, 2016 LONDON–(BUSINESS WIRE)–According to the latest market study released by Technavio, the global bioactive wound care market is…
Read More » -
Biologics
Scientists develop technology to produce bioactive coating with antibacterial effect
By InSerbia with agencies BELGRADE – A group of NUST MISIS scientists developed an innovative technology for producing a bioactive…
Read More »